Kiora Pharmaceuticals, Inc. (KPRX)
2.49
-0.02
(-0.80%)
USD |
NASDAQ |
Sep 09, 15:06
Kiora Pharmaceuticals Shareholders Equity (Quarterly) : 16.86M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 16.86M |
| March 31, 2026 | 13.93M |
| December 31, 2025 | 16.13M |
| September 30, 2025 | 22.41M |
| June 30, 2025 | 22.13M |
| March 31, 2025 | 23.70M |
| December 31, 2024 | 25.76M |
| September 30, 2024 | 30.03M |
| June 30, 2024 | 33.10M |
| March 31, 2024 | 34.90M |
| December 31, 2023 | 6.110M |
| September 30, 2023 | 8.104M |
| June 30, 2023 | 13.64M |
| March 31, 2023 | 10.16M |
| December 31, 2022 | 11.41M |
| September 30, 2022 | 10.52M |
| June 30, 2022 | 8.762M |
| March 31, 2022 | 11.26M |
| December 31, 2021 | 14.58M |
| September 30, 2021 | 17.35M |
| June 30, 2021 | 10.45M |
| March 31, 2021 | 12.68M |
| December 31, 2020 | 9.730M |
| September 30, 2020 | 5.961M |
| June 30, 2020 | 7.798M |
| Date | Value |
|---|---|
| March 31, 2020 | 9.318M |
| December 31, 2019 | 6.622M |
| September 30, 2019 | 5.212M |
| June 30, 2019 | 8.472M |
| March 31, 2019 | 10.04M |
| December 31, 2018 | 8.936M |
| September 30, 2018 | 11.10M |
| June 30, 2018 | 13.55M |
| March 31, 2018 | 5.278M |
| December 31, 2017 | -1.927M |
| September 30, 2017 | 0.6794M |
| June 30, 2017 | 4.628M |
| March 31, 2017 | -1.088M |
| December 31, 2016 | -0.2706M |
| September 30, 2016 | 3.304M |
| June 30, 2016 | 6.527M |
| March 31, 2016 | 6.726M |
| December 31, 2015 | 6.146M |
| September 30, 2015 | 8.736M |
| June 30, 2015 | 0.9725M |
| March 31, 2015 | 2.193M |
| December 31, 2014 | -10.34M |
| September 30, 2014 | -9.834M |
| June 30, 2014 | -10.39M |
| March 31, 2014 | -9.177M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| ANI Pharmaceuticals, Inc. | 597.21M |
| Corcept Therapeutics, Inc. | 705.78M |
| Veru, Inc. | 28.38M |
| Johnson & Johnson | 84.97B |
| Eli Lilly & Co. | 33.88B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 23.78M |
| Total Liabilities (Quarterly) | 6.919M |
| Debt to Equity Ratio | 0.0198 |
| Current Ratio | 8.970 |
| Net Debt Paydown Yield | -0.30% |